Company news

Biomerica, Inc. news in 2023

Biomerica, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population

December 17, 2023

Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups

November 7, 2023

Biomerica Reports First Quarter 2024 Financial Results

October 12, 2023

Diagnostics Industry Leader Jack Kenny Joins Biomerica’s Board of Directors

August 27, 2023

Biomerica Reports Fiscal 2023 Year End Results

August 24, 2023

Biomerica’s inFoods® IBS test is now available at Gastro Health, providing a revolutionary new treatment for patients suffering from Irritable Bowel Syndrome (IBS).

April 16, 2023

Biomerica Reports Q3 Fiscal 2023 Results

April 13, 2023

Biomerica announces the Launch of InFoods IBS as a Laboratory Developed Test (LDT); First patient samples have been processed

March 7, 2023

Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock

March 6, 2023

Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock

March 2, 2023

Biomerica Announces Proposed Underwritten Public Offering of Common Stock

March 1, 2023

Biomerica Reports Financial Results for Fiscal 2023 Second Quarter Ended November 30, 2022

January 12, 2023

Biomerica Appoints Mayo Clinic Gastroenterologist, Dr. Brian E. Lacy, to the Company’s Scientific Advisory Board

January 9, 2023

Decks in 2023